AAPK-25

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameAAPK-25
Drug Alias NameAAPK-25
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora inhibitorsPolo like kinase 4 inhibitors
TargetsSerine/threonine-protein kinase AuroraPolo like kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Electronic Science And Technology Of China
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Electronic Science And Technology Of China
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A